Get the Stockscreener App
10.46
0.09%
0.0091
Translational Development Acquisition Corp stock is traded at $10.46, with a volume of 1,324.
It is up +0.09% in the last 24 hours and up +0.10% over the past month.
Translational Development Acquisition Corp is a newly organized blank check company.
See More
Previous Close:
$10.45
Open:
$10.44
24h Volume:
1,324
Relative Volume:
0.04
Market Cap:
$229.15M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.19%
1M Performance:
+0.10%
6M Performance:
+2.07%
1Y Performance:
+0.00%
1-Day Range:
$10.44
$10.48
1-Week Range:
$10.44
$10.48
52-Week Range:
$10.00
$10.48
Translational Development Acquisition Corp Stock (TDAC) Company Profile
Name
Translational Development Acquisition Corp
Sector
Industry
Phone
(413) 204-2769
Address
52 E 83RD ST., NEW YORK
Compare TDAC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDAC
Translational Development Acquisition Corp
|
10.46 | 228.95M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
7.85 | 2.22B | 3.13B | -174.20M | -111.20M | -0.6937 |
|
CCCX
Churchill Capital Corp X
|
14.01 | 750.04M | 0 | 0 | 0 | 0.00 |
|
DMII
Drugs Made In America Acquisition Ii Corp
|
9.88 | 647.88M | 0 | 0 | 0 | 0.00 |
|
BCSS
Bain Capital Gss Investment Corp
|
10.09 | 588.96M | 0 | 0 | 0 | 0.00 |
|
CEPF
Cantor Equity Partners Iv Inc
|
10.29 | 589.22M | 0 | 0 | 0 | 0.00 |
Translational Development Acquisition Corp Stock (TDAC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-21-21 | Initiated | Northland Capital | Outperform |
Translational Development Acquisition Corp Stock (TDAC) Latest News
Weekly Earnings: Is Translational Development Acquisition Corp Equity Warrant stock trading at a premium valuationMarket Performance Report & Verified Momentum Stock Watchlist - BỘ NỘI VỤ
Valuation Update: Is Bleichroeder Acquisition Corp I Equity Right stock a defensive play in 2025 - BỘ NỘI VỤ
Is Hikal Limited a Top Growth Stock to Watch in YEARMarket Sentiment Indicators & Fast Growing Portfolio - earlytimes.in
Patterns Watch: How Coherus BioSciences Inc stock reacts to bond yieldsEarnings Overview Summary & Verified Swing Trading Watchlist - BỘ NỘI VỤ
Will Translational Development Acquisition Corp. Equity Warrant stock benefit from AI adoption2025 Market Trends & Real-Time Buy Zone Alerts - Newser
Why Translational Development Acquisition Corp. stock could outperform in 2025Gap Down & Stepwise Trade Signal Implementation - Newser
Can Translational Development Acquisition Corp. stock deliver consistent earnings growth2025 Retail Activity & Risk Managed Investment Signals - Newser
Why Translational Development Acquisition Corp. Equity Warrant stock remains resilientQuarterly Investment Review & Weekly Watchlist of Top Performers - Newser
Translational Development Acquisition Corp Equity Warrant Stock Analysis and ForecastIndustrial Stocks Review & Free Rapid Portfolio Appreciation - earlytimes.in
Translational Development (TDACU) Stock Analysis Report | Financials & Insights - Benzinga
Hindustan Foods Limited May Be Forming Higher Low Chartwatchers AlertMarket Insider Reports & Low Risk Trading Ideas - earlytimes.in
Why Translational Development Acquisition Corp. stock appeals to analystsTrade Risk Assessment & AI Based Trade Execution Alerts - newser.com
What Technical Resistance Could Cap Toss the Coin Limiteds Upside - earlytimes.in
Is this a good reentry point in Translational Development Acquisition Corp. Equity Warrant2025 Momentum Check & AI Enhanced Execution Alerts - newser.com
How sustainable is Translational Development Acquisition Corp. Equity Warrant stock dividend payoutTrade Risk Assessment & Smart Allocation Stock Tips - newser.com
How Translational Development Acquisition Corp. stock benefits from tech adoptionRecession Risk & Accurate Buy Signal Notifications - newser.com
Is Translational Development Acquisition Corp. stock overvalued by current metricsJuly 2025 Trends & Stepwise Trade Signal Guides - newser.com
Why Translational Development Acquisition Corp. stock could benefit from AI revolution2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com
Can Translational Development Acquisition Corp. stock double in next 5 yearsMarket Sentiment Review & Fast Gain Stock Trading Tips - newser.com
Can Translational Development Acquisition Corp. stock attract ESG capital inflowsSell Signal & AI Powered Market Entry Strategies - newser.com
Is Translational Development Acquisition Corp. Equity Warrant stock supported by innovation pipelineFed Meeting & Smart Money Movement Alerts - newser.com
Why VNET Group Inc. Depositary Receipt stock remains on buy lists - newser.com
Real time alert setup for Translational Development Acquisition Corp. Equity Warrant performanceGap Down & AI Powered Trade Plan Recommendations - newser.com
Will Translational Development Acquisition Corp. Equity Warrant stock continue dividend increasesQuarterly Risk Review & Expert Verified Movement Alerts - newser.com
Is Translational Development Acquisition Corp. Equity Warrant stock cheap at current valuationRate Cut & Daily Risk Controlled Trade Plans - newser.com
Volatility clustering patterns for Translational Development Acquisition Corp.Quarterly Profit Summary & High Conviction Buy Zone Picks - newser.com
Will Translational Development Acquisition Corp. Equity Warrant stock deliver strong dividend growthLayoff News & Safe Entry Point Alerts - newser.com
Translational Development Acquisition Corp Stock (TDAC) Financials Data
There is no financial data for Translational Development Acquisition Corp (TDAC). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.10%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):